Standard BioTools Inc. (LAB) Stock Split, History Data
Working capital analysis
In terms of working capital, Standard BioTools Inc. maintains a healthy position.
The total current assets of the company are valued at $158215000.
This represents a growth rate of -24.232% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $51704000, exhibiting a growth rate of -36.410% year-on-year.
The receivables, another significant portion of the current assets, are valued at $19660000.
The year-on-year growth rate for receivables is 13.773%.
The inventory, which forms a critical part of the assets, is valued at $20533000.
This represents a healthy year-on-year growth of -4.378%
On the liabilities side, the company's current liabilities total $109327000.
This reflects a growth rate of 151.656% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
51.70
81.31
28.45
68.52
21.66
95.40
Receavebles
19.66
17.28
18.32
25.42
18.98
16.65
Inventory
20.53
21.47
20.82
19.69
13.88
13.00
Other
3.13
4.28
4.47
4.03
4.59
2.05
Total Current Assets
158.22
208.81
72.07
117.66
96.10
127.11
Acc Payable
9.24
7.91
10.60
9.22
6.51
4.03
Short Term Debt
63.85
5.76
9.89
2.97
1.83
0.00
Other Current Liab
20.57
15.33
13.59
28.58
12.68
22.09
Current Liabilities
109.33
43.44
49.57
54.25
32.82
37.58
Capital Structure
When examining the capital structure of Standard BioTools Inc., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Standard BioTools Inc. has chosen to reinvest in the business rather than distribute as dividends.
